[1]
Amer Mahmood et al. 2022. EFFICACY OF NARINGIN IN PROTECTING CARDIAC H9C2 CELLS FROM HYPERGLYCEMIC DAMAGE: POTENTIAL IMPLICATIONS FOR DIABETIC CARDIOMYOPATHY TREATMENT. Journal of Population Therapeutics and Clinical Pharmacology. 29, 01 (Mar. 2022), 219–228. DOI:https://doi.org/10.53555/jptcp.v29i01.3303.